BioMerieux SA Stock Xetra
Equities
EYW
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.9B 4.19B 5.77B | Sales 2025 * | 4.19B 4.51B 6.2B | Capitalization | 10.87B 11.68B 16.07B |
---|---|---|---|---|---|
Net income 2024 * | 465M 500M 688M | Net income 2025 * | 527M 566M 779M | EV / Sales 2024 * | 2.73 x |
Net cash position 2024 * | 217M 234M 321M | Net cash position 2025 * | 400M 430M 591M | EV / Sales 2025 * | 2.5 x |
P/E ratio 2024 * |
23.9
x | P/E ratio 2025 * |
21.1
x | Employees | - |
Yield 2024 * |
0.97% | Yield 2025 * |
1.13% | Free-Float | 36.23% |
Latest transcript on BioMerieux SA
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 16-10-31 |
Chairman | 50 | 04-04-15 | |
Director of Finance/CFO | 47 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 06-09-14 | |
Director/Board Member | 63 | 04-12-31 | |
Chairman | 50 | 04-04-15 |
1st Jan change | Capi. | |
---|---|---|
-2.58% | 8.27B | |
+7.95% | 5.81B | |
+28.92% | 5.58B | |
-15.77% | 3.85B | |
+12.42% | 2.71B | |
-64.08% | 2.56B | |
-9.60% | 2.42B | |
+21.73% | 2.13B | |
-9.25% | 1.77B |